Pro-Dex, Inc. (PDEX)
65.37
+2.79
(+4.46%)
USD |
NASDAQ |
Sep 03, 16:00
67.00
+1.63
(+2.49%)
After-Hours: 20:00
Pro-Dex Research and Development Expense (TTM) : 3.234M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 3.234M |
| December 31, 2025 | 3.354M |
| September 30, 2025 | 3.562M |
| June 30, 2025 | 3.637M |
| March 31, 2025 | 3.568M |
| December 31, 2024 | 3.381M |
| September 30, 2024 | 3.227M |
| June 30, 2024 | 3.189M |
| March 31, 2024 | 3.048M |
| December 31, 2023 | 3.001M |
| September 30, 2023 | 2.68M |
| June 30, 2023 | 2.804M |
| March 31, 2023 | 2.835M |
| December 31, 2022 | 2.78M |
| September 30, 2022 | 2.928M |
| June 30, 2022 | 2.979M |
| March 31, 2022 | 3.453M |
| December 31, 2021 | 3.899M |
| September 30, 2021 | 4.273M |
| June 30, 2021 | 4.384M |
| March 31, 2021 | 3.999M |
| December 31, 2020 | 3.515M |
| September 30, 2020 | 2.923M |
| June 30, 2020 | 2.316M |
| March 31, 2020 | 2.046M |
| Date | Value |
|---|---|
| December 31, 2019 | 2.029M |
| September 30, 2019 | 1.958M |
| June 30, 2019 | 1.882M |
| March 31, 2019 | 1.785M |
| December 31, 2018 | 1.742M |
| September 30, 2018 | 1.894M |
| June 30, 2018 | 1.893M |
| March 31, 2018 | 1.831M |
| December 31, 2017 | 1.528M |
| September 30, 2017 | 1.328M |
| June 30, 2017 | 1.225M |
| March 31, 2017 | 1.214M |
| December 31, 2016 | 1.258M |
| September 30, 2016 | 1.244M |
| June 30, 2016 | 1.368M |
| March 31, 2016 | 1.352M |
| December 31, 2015 | 1.531M |
| September 30, 2015 | 1.711M |
| June 30, 2015 | 1.667M |
| March 31, 2015 | 1.669M |
| December 31, 2014 | 1.57M |
| September 30, 2014 | 1.49M |
| June 30, 2014 | 1.481M |
| March 31, 2014 | 1.55M |
| December 31, 2013 | 1.659M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Abbott Laboratories | 3.128B |
| AngioDynamics, Inc. | 29.45M |
| Alphatec Holdings, Inc. | 76.69M |
| AtriCure, Inc. | 94.05M |
| Baxter International, Inc. | 480.00M |